TTOO Price to Sales Ratio vs Net Income Analysis

TTOO Stock

USD 2.99 0.05 1.70%

T2 Biosystms financial indicator trend analysis is much more than just breaking down T2 Biosystms prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether T2 Biosystms is a good investment. Please check the relationship between T2 Biosystms Price To Sales Ratio and its Net Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

Price To Sales Ratio vs Net Income

Price to Sales Ratio vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of T2 Biosystms Price to Sales Ratio account and Net Income. At this time, the significance of the direction appears to have very strong relationship.

The correlation between T2 Biosystms' Price to Sales Ratio and Net Income is 0.81. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Net Income in the same time period over historical financial statements of T2 Biosystms, assuming nothing else is changed. The correlation between historical values of T2 Biosystms' Price to Sales Ratio and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of T2 Biosystms are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Price to Sales Ratio i.e., T2 Biosystms' Price to Sales Ratio and Net Income go up and down completely randomly.

Correlation Coefficient

0.81

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing T2 Biosystms stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on T2 Biosystms sales, a figure that is much harder to manipulate than other T2 Biosystms multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in T2 Biosystms financial statement analysis. It represents the amount of money remaining after all of T2 Biosystms operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from T2 Biosystms' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.As of the 19th of April 2024, Enterprise Value is likely to grow to about 75.5 M, while Selling General Administrative is likely to drop about 26 M.

	2021	2022	2023	2024 (projected)
Interest Expense	6.6M	6.1M	5.3M	4.9M
Depreciation And Amortization	318K	39K	859K	843.9K

Interest Expense Depreciation And Amortization

T2 Biosystms fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.49	0.19	0.0	0.92	0.06	0.6	-0.33	-0.13	0.08	0.81	0.59	0.46	0.26	0.38	0.92	0.15	-0.09	0.2	-0.35	0.28	0.33	-0.56	0.31	0.97	-0.06
Short Long Term Debt Total	0.49		0.81	0.49	0.44	0.61	0.93	0.61	-0.87	0.58	0.04	0.87	-0.24	0.38	0.84	0.16	0.79	0.23	0.43	-0.5	0.86	0.96	-0.3	0.78	0.31	0.38
Other Current Liab	0.19	0.81		0.82	0.25	0.35	0.62	0.57	-0.79	0.68	-0.07	0.51	-0.31	0.01	0.73	-0.05	0.6	0.36	0.5	-0.72	0.67	0.84	-0.28	0.66	0.08	0.74
Total Current Liabilities	0.0	0.49	0.82		0.1	0.2	0.29	0.41	-0.6	0.37	-0.04	0.17	-0.33	-0.43	0.37	-0.09	0.4	0.61	0.34	-0.81	0.32	0.54	-0.29	0.58	-0.03	0.99
Total Stockholder Equity	0.92	0.44	0.25	0.1		-0.06	0.5	-0.37	-0.09	0.02	0.82	0.45	0.43	0.21	0.35	0.88	0.07	-0.04	0.16	-0.58	0.23	0.29	-0.83	0.27	0.92	0.04
Other Liab	0.06	0.61	0.35	0.2	-0.06		0.56	0.71	-0.83	0.32	-0.33	0.61	-0.6	0.18	0.57	-0.21	0.95	0.61	-0.03	-0.03	0.81	0.7	0.09	0.81	-0.09	0.14
Property Plant And Equipment Net	0.6	0.93	0.62	0.29	0.5	0.56		0.48	-0.73	0.54	0.15	0.94	-0.03	0.4	0.74	0.29	0.69	0.12	0.33	-0.35	0.73	0.84	-0.27	0.74	0.43	0.17
Net Debt	-0.33	0.61	0.57	0.41	-0.37	0.71	0.48		-0.81	0.59	-0.75	0.52	-0.58	0.14	0.53	-0.65	0.79	0.34	0.35	-0.09	0.69	0.7	0.26	0.58	-0.51	0.35
Retained Earnings	-0.13	-0.87	-0.79	-0.6	-0.09	-0.83	-0.73	-0.81		-0.57	0.27	-0.68	0.61	-0.17	-0.8	0.18	-0.95	-0.57	-0.3	0.43	-0.89	-0.94	0.1	-0.88	0.03	-0.52
Accounts Payable	0.08	0.58	0.68	0.37	0.02	0.32	0.54	0.59	-0.57		-0.28	0.51	-0.17	0.21	0.61	-0.18	0.5	0.03	0.59	-0.22	0.59	0.57	0.04	0.42	-0.05	0.26
Cash	0.81	0.04	-0.07	-0.04	0.82	-0.33	0.15	-0.75	0.27	-0.28		0.04	0.46	0.04	0.0	0.96	-0.29	-0.09	-0.14	-0.34	-0.19	-0.11	-0.61	-0.01	0.92	-0.05
Non Current Assets Total	0.59	0.87	0.51	0.17	0.45	0.61	0.94	0.52	-0.68	0.51	0.04		0.08	0.36	0.68	0.25	0.7	0.06	0.44	-0.21	0.73	0.78	-0.18	0.67	0.39	0.06
Non Currrent Assets Other	0.46	-0.24	-0.31	-0.33	0.43	-0.6	-0.03	-0.58	0.61	-0.17	0.46	0.08		-0.09	-0.33	0.54	-0.6	-0.61	0.23	0.07	-0.47	-0.39	-0.18	-0.46	0.48	-0.32
Other Assets	0.26	0.38	0.01	-0.43	0.21	0.18	0.4	0.14	-0.17	0.21	0.04	0.36	-0.09		0.28	0.11	0.21	-0.52	0.02	0.25	0.4	0.28	-0.01	-0.06	0.19	-0.51
Long Term Debt	0.38	0.84	0.73	0.37	0.35	0.57	0.74	0.53	-0.8	0.61	0.0	0.68	-0.33	0.28		0.09	0.73	0.27	0.5	-0.39	0.86	0.88	-0.23	0.69	0.24	0.27
Cash And Short Term Investments	0.92	0.16	-0.05	-0.09	0.88	-0.21	0.29	-0.65	0.18	-0.18	0.96	0.25	0.54	0.11	0.09		-0.16	-0.13	0.0	-0.3	-0.05	-0.01	-0.59	0.07	0.98	-0.11
Common Stock Total Equity	0.15	0.79	0.6	0.4	0.07	0.95	0.69	0.79	-0.95	0.5	-0.29	0.7	-0.6	0.21	0.73	-0.16		0.59	0.18	-0.27	0.91	0.86	-0.06	0.88	-0.01	0.32
Common Stock Shares Outstanding	-0.09	0.23	0.36	0.61	-0.04	0.61	0.12	0.34	-0.57	0.03	-0.09	0.06	-0.61	-0.52	0.27	-0.13	0.59		-0.23	-0.46	0.35	0.37	-0.2	0.75	-0.1	0.62
Short Term Investments	0.2	0.43	0.5	0.34	0.16	-0.03	0.33	0.35	-0.3	0.59	-0.14	0.44	0.23	0.02	0.5	0.0	0.18	-0.23		-0.26	0.34	0.39	-0.02	0.07	0.1	0.3
Non Current Liabilities Total	-0.35	-0.5	-0.72	-0.81	-0.58	-0.03	-0.35	-0.09	0.43	-0.22	-0.34	-0.21	0.07	0.25	-0.39	-0.3	-0.27	-0.46	-0.26		-0.28	-0.47	0.78	-0.5	-0.35	-0.79
Other Current Assets	0.28	0.86	0.67	0.32	0.23	0.81	0.73	0.69	-0.89	0.59	-0.19	0.73	-0.47	0.4	0.86	-0.05	0.91	0.35	0.34	-0.28		0.92	-0.12	0.75	0.12	0.22
Other Stockholder Equity	0.33	0.96	0.84	0.54	0.29	0.7	0.84	0.7	-0.94	0.57	-0.11	0.78	-0.39	0.28	0.88	-0.01	0.86	0.37	0.39	-0.47	0.92		-0.19	0.82	0.16	0.44
Total Liab	-0.56	-0.3	-0.28	-0.29	-0.83	0.09	-0.27	0.26	0.1	0.04	-0.61	-0.18	-0.18	-0.01	-0.23	-0.59	-0.06	-0.2	-0.02	0.78	-0.12	-0.19		-0.27	-0.6	-0.26
Property Plant And Equipment Gross	0.31	0.78	0.66	0.58	0.27	0.81	0.74	0.58	-0.88	0.42	-0.01	0.67	-0.46	-0.06	0.69	0.07	0.88	0.75	0.07	-0.5	0.75	0.82	-0.27		0.18	0.5
Total Current Assets	0.97	0.31	0.08	-0.03	0.92	-0.09	0.43	-0.51	0.03	-0.05	0.92	0.39	0.48	0.19	0.24	0.98	-0.01	-0.1	0.1	-0.35	0.12	0.16	-0.6	0.18		-0.07
Short Term Debt	-0.06	0.38	0.74	0.99	0.04	0.14	0.17	0.35	-0.52	0.26	-0.05	0.06	-0.32	-0.51	0.27	-0.11	0.32	0.62	0.3	-0.79	0.22	0.44	-0.26	0.5	-0.07

Click cells to compare fundamentals

T2 Biosystms Account Relationship Matchups

T2 Biosystms fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	28.5M	79.1M	60.5M	34.4M	34.8M	43.7M
Short Long Term Debt Total	44.8M	55.8M	57.1M	59.2M	49.5M	42.0M
Other Current Liab	13.6M	6.4M	7.2M	7.7M	11.5M	7.1M
Total Current Liabilities	60.6M	9.8M	11.7M	10.5M	56.2M	59.0M
Total Stockholder Equity	(34.0M)	8.7M	(12.9M)	(40.0M)	(28.0M)	(26.6M)
Other Liab	46K	4.8M	4.6M	4.9M	5.6M	5.9M
Property Plant And Equipment Net	9.2M	14.8M	14.4M	13.3M	9.1M	9.8M
Net Debt	33.7M	39.0M	34.9M	48.9M	33.8M	35.5M
Retained Earnings	(376.2M)	(423.0M)	(472.2M)	(534.5M)	(584.3M)	(555.1M)
Accounts Payable	3.8M	2.1M	2.8M	1.3M	1.5M	1.6M
Cash	11.0M	16.8M	22.2M	10.3M	15.7M	28.6M
Non Current Assets Total	9.6M	25.5M	16.1M	15.0M	9.7M	11.6M
Cash And Short Term Investments	11.0M	42.2M	32.2M	10.3M	15.7M	31.0M
Common Stock Total Equity	36K	44K	51K	147K	169.1K	177.5K
Common Stock Shares Outstanding	9.1K	24.3K	31.8K	51.0K	2.6M	2.7M
Liabilities And Stockholders Equity	28.5M	79.1M	60.5M	34.4M	34.8M	43.7M
Non Current Liabilities Total	1.9M	60.6M	61.8M	63.9M	6.7M	6.3M
Other Current Assets	1.4M	2.7M	3.1M	2.6M	3.2M	1.7M
Other Stockholder Equity	342.1M	431.5M	459.2M	494.6M	556.3M	315.0M
Total Liab	62.5M	70.4M	73.4M	74.4M	62.8M	50.8M
Property Plant And Equipment Gross	9.2M	14.8M	14.4M	13.3M	23.9M	25.1M
Total Current Assets	18.9M	53.6M	44.4M	19.4M	25.1M	35.3M
Accumulated Other Comprehensive Income	(11.3M)	(13.2M)	9K	(4K)	(3.6K)	(3.8K)
Short Term Debt	42.9M	1.2M	1.2M	1.4M	42.9M	45.0M
Common Stock	49K	147K	166K	8K	4K	3.8K
Property Plant Equipment	5.8M	14.8M	14.4M	13.3M	15.3M	9.5M
Net Tangible Assets	(32.1M)	8.7M	(12.9M)	(40.0M)	(36.0M)	(34.2M)
Current Deferred Revenue	285K	230K	518K	172K	224K	212.8K
Net Receivables	2.8M	5.1M	5.1M	2.2M	1.4M	2.2M
Retained Earnings Total Equity	(266.1M)	(317.2M)	(376.2M)	(423.0M)	(380.7M)	(399.7M)
Capital Surpluse	267.4M	328.5M	342.1M	431.5M	496.3M	308.8M
Inventory	3.6M	3.6M	3.9M	4.3M	4.8M	2.9M
Short Long Term Debt	40.7M	42.4M	42.9M	41.3M	47.5M	27.2M
Capital Lease Obligations	3.9M	10.5M	9.4M	9.6M	8.2M	6.1M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards T2 Biosystms in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, T2 Biosystms' short interest history, or implied volatility extrapolated from T2 Biosystms options trading.

Currently Active Assets on Macroaxis

BAC	Bank of America
DD	Dupont De Nemours
F	Ford Motor
WD	Walker Dunlop
GOOG	Alphabet Inc Class C

When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:

How To Invest In TTOO

Details

Is TTOO Stock a good investment?

Details

What is T2 Biosystms' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for TTOO Stock analysis

When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.

	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(19.19)

Revenue Per Share

2.756

Quarterly Revenue Growth

(0.69)

Return On Assets

(0.85)

Return On Equity

(6.22)

The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TTOO Price to Sales Ratio vs Net Income Analysis

Price To Sales Ratio vs Net Income

Price to Sales Ratio vs Net Income Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Net Income

T2 Biosystms fundamental ratios Correlations

T2 Biosystms Account Relationship Matchups

High Positive Relationship

High Negative Relationship

T2 Biosystms fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for TTOO Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 0.99	Total Current Liabilities
Total Current Assets	+ 0.98	Cash And Short Term Investments
Total Current Assets	+ 0.97	Total Assets
Other Stockholder Equity	+ 0.96	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.96	Cash
Common Stock Total Equity	+ 0.95	Other Liab

Common Stock Total Equity	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Other Current Assets	- 0.89	Retained Earnings
Property Plant And Equipment Gross	- 0.88	Retained Earnings
Retained Earnings	- 0.87	Short Long Term Debt Total
Retained Earnings	- 0.83	Other Liab